Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Muted Friday Unable To Dent Positive Week

Fri, 27th Nov 2020 17:03

(Alliance News) - Stocks in London limped to a lacklustre end to the week on Friday, with AstraZeneca's potential coronavirus vaccine coming under increased scrutiny.

The UK government said it has asked its independent medicines regulator to assess AstraZeneca's vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.

AstraZeneca has completed phase 3 clinical trials of its vaccine, the last stage before regulatory approval. But under British rules, the government must also ask the independent Medicines & Healthcare products Regulatory Agency to green light the drug.

Astra added 0.4% Friday.

On Thursday, the head of British drug manufacturer AstraZeneca said further research was needed on its Covid-19 vaccine after questions emerged over the protection it could offer.

"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Chief Executive Pascal Soriot told Bloomberg in an interview.

The FTSE 100 index added 4.65 points, or 0.1%, at 6,367.58. The large-cap index added 0.6 % this week.

The mid-cap FTSE 250 index gained 66.37 points, or 0.3%, at 19,462.71. The AIM All-Share index ended slightly higher, gaining 0.98 of a point, at 1,039.01.

The Cboe UK 100 index closed 0.1% higher at 634.21. The Cboe 250 closed down 1.0% at 16,581.96. The Cboe Small Companies ended down 1.5% at 11,276.56.

"As the final full week of November trading winds down we find markets still in a guardedly-positive mood. It has been a great month, continuing of course the strong run since March for many markets, and while it might not be going out on a high there is still no sign of any correction on the horizon," IG's Chief Market Analyst Chris Beauchamp said.

He continued: "However, high sentiment and breadth readings should give investors pause, with a legitimate question being how much of the expected December gain has been pulled forward into the preceding month. While election concerns seem to have almost entirely disappeared, and rightly so given Trump's comments about making way for the new administration, the virus situation remains, and still has the power to shock should the Thanksgiving holiday produce another surge in US cases."

UK stocks were underperforming those in in mainland Europe. The CAC 40 in Paris and the DAX 30 in Frankfurt advanced 0.6% and 0.4%, respectively.

"The difference between the FTSE and its Western peers is the underlying Brexit talk anxieties that are only going to become more pronounced in the coming days and weeks - and sent the pound 0.3% lower against the euro - and fears that the Oxford/AstraZeneca vaccine might not be quite as effective as first claimed," SpreadEx analyst Connor Campbell.

A Brexit deal is still possible, the UK's chief negotiator has insisted as face-to-face negotiations are set to resume with the clock ticking down to an agreement deadline.

But David Frost warned that a deal is only possible if Brussels recognised British sovereignty in key areas.

Frost was speaking ahead of face-to-face talks, which he said would take place on Saturday.

The comments came after EU chief negotiator Michel Barnier warned that "significant divergences" still remain ahead of the UK exiting the Brexit transition period at the end of December.

The pound was quoted at USD1.3331 on Friday evening, broadly flat from USD1.3333 at the London equities close Thursday.

The euro stood at USD1.1957, up from USD1.1908. Against the Japanese yen, the dollar was trading at JPY103.99, down from JPY104.27.

Wall Street was painted green on Friday's half-day, with the Dow Jones Industrial Average up 0.1%, the S&P 500 up 0.3% and the Nasdaq Composite up 1.1%.

Financial markets in the US reopened for a half-day on Friday after being closed on Thursday for Thanksgiving.

In London, Homserve gave back 1.3%. The home emergency cover provider finds itself on the brink of automatic demotion from the large-cap index ahead of the FTSE Russell index review changes next week. Homeserve currently ranks 115th in the FTSE 350 by market capitalisation, just below the safety threshold at 110th place, with a total market value of GBP3.4 billion.

In the FTSE 250, Indivior was the worst performer, closing down 20% after the drugmaker said Reckitt Benckiser has submitted a GBP1.07 billion claim against the company.

The claim related to an indemnity contained in the demerger agreement entered into between the two companies in November 2014. Indivior spun off from consumer health and hygiene firm Reckitt and listed on the London Stock Exchange in December of that year.

The claim was submitted on November 13.

Indivior said: "The claim has not been served on the company and the company does not have any further details at this time. The company will assess with its advisors the background and merits to the case and will provide an update in due course."

Reckitt lost 1.3% Friday.

JD Wetherspoon bounced back in afternoon trade, gaining 1.2%, despite opening down 4.9%. The pub chain complained bitterly about the UK government's post-lockdown tier system, which effectively forces almost half of its about 870 pubs to close.

Just 13 Wetherspoon pubs in England are in areas classified as Tier 1, under the new UK virus restrictions that go into place from next week. In addition, there are 51 pubs in Wales, where the regulations equate to Tier 1 in England.

In Tier 1, the rule of six applies indoors and outdoors, but in Tier 2 there will be a ban on households mixing indoors, and pubs and restaurants will only be able to sell alcohol with a "substantial meal". Tier 3 measures mean a ban on households mixing, except in limited circumstances such as in parks.

For Wetherspoon, Tier 2 affects 435 pubs. This tier includes 17 pubs in Scotland where the regulations approximate to Tier 2 in England, the pub chain said.

"These rules greatly reduced pub capacity and provided strict social distancing and hygiene standards but, with difficultly, allowed pubs to trade viably. It is very disappointing that yet another raft of regulations has been introduced, which has effectively closed half our pubs," said Chair Tim Martin.

Brent oil was trading at USD48.05 a barrel Friday evening, up from USD47.77 late Thursday. Gold fetched USD1,786.40 an ounce, lower from USD1,810.32.

A busy global economic calendar next week is headlined by US Fed Chair Jerome Powell testifying before Congress on Tuesday and US non-farm payrolls and unemployment on Friday.

On Monday, there is China non-manufacturing PMI overnight and German consumer price index at 1300 GMT. There is a slew of manufacturing manufacturing PMIs, with Japan and China overnight, followed by Germany, eurozone, and UK at 0855 GMT, 0900 GMT and 0930 GMT, respectively. US Markit manufacturing is due 1445 GMT.

On Thursday, there will be a run of service PMI readings, with China and Japan overnight, then Germany, eurozone and UK at 0855 GMT, 0900 GMT and 0930 GMT, respectively. US ISM services at 1500 GMT.

The local corporate calendar on Monday has half-year results from electronic parts supplier discoverIE Group, carpet designer Victoria, venture capital firm Draper Esprit, and social housing investor Civitas Social Housing.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.